|
|
| |
Stocks in Depth
Decision
by WealthEffect Staff |
|
| |
 |
Coca-Cola's Checklist |
|
| |
 |
Other Considerations |
|
| |
 |
Buy the Stock? |
|
| |
1. |
Checklist the Coca-Cola Company |
|
| |
Company |
Yes |
No |
|
| |
 |
Do you really understand the business? |
 |
 |
|
| |
 |
Does the company have a cost advantage? |
 |
 |
|
| |
 |
Is the product superior actual or perceived? |
 |
 |
|
| |
 |
Are there barriers to entry in the industry? |
 |
 |
|
| |
 |
Is the industry an oligopoly (only a few competitors)? |
 |
 |
|
| |
 |
Are the company's advantages sustainable? |
 |
 |
|
| |
Management |
Yes |
No |
|
| |
 |
Do the managers own a lot of stock? Are they buying more for themselves? (If they're selling, be wary) |
 |
 |
|
| |
 |
Do they have a vision, and a strategy to realize that vision? |
 |
 |
|
| |
 |
Are they paid fairly? |
 |
 |
|
| |
 |
Has the stock outperformed its competitors during their tenure? |
 |
 |
|
| |
 |
Is the Board of Directors predominantly comprised of independent, highly capable members? |
 |
 |
|
| |
 |
Do you trust the management with your money? Are the managers focused on creating shareholder value? |
 |
 |
|
| |
Stock |
Yes |
No |
|
| |
 |
Has the earnings per share (eps) growth been stable? (last 10 years vs. last 20)
|
 |
 |
|
| |
 |
Are eps estimates rising? |
 |
 |
|
| |
 |
Is the free cash flow positive after deducting dividends? |
 |
 |
|
| |
 |
Is the company repurchasing shares? |
 |
 |
|
| |
 |
Is the stock out of favor on Wall Street? |
 |
 |
|
| |
 |
Is the expected ROI attractive to you? |
 |
 |
|
| |
Checklist Advanced |
|
| |
Company |
Yes |
No |
|
| |
 |
Is the pretax margin higher than its competitors? |
 |
 |
|
| |
 |
Has the pretax margin been rising over time? |
 |
 |
|
| |
 |
Has the R&D ratio been rising, as well? |
 |
 |
|
| |
 |
Has the SG&A ratio been declining? |
 |
 |
|
| |
 |
Is the interest coverage ratio above 3? |
 |
 |
|
| |
 |
Have accounts receivable and inventories been rising less than or equal to sales growth? |
 |
 |
|
| |
 |
Has sales growth been reasonably close to earnings growth? |
 |
 |
|
| |
 |
Have sales and earnings growth come primarily from internal growth (rather than from acquisitions)? |
 |
 |
|
| |
 |
Have "non-recurring" charges been few and far between? |
 |
 |
|
| |
Management |
Yes |
No |
|
| |
 |
Has the compensation of the top five managers accounted for < 10% of pretax income? |
 |
 |
|
| |
 |
Have company options accounted for less than 10% of pretax income? Has the company avoided the questionable practice of repricing options when the stock price declined? |
 |
 |
|
| |
 |
Is the Chairman of the Board an outside board member? |
 |
 |
|
| |
 |
Have there been no disagreements with or changes of auditors? |
 |
 |
|
| |
Stock |
Yes |
No |
|
| |
 |
Is the 10-year RORE greater than 20%? |
 |
 |
|
| |
 |
Has the RORE been rising (5-yr > 10-yr)? |
 |
 |
|
| |
 |
Is the operating free cash flow positive after dividends? |
 |
 |
|
| |
 |
Is the operating discretionary cash flow significant? |
 |
 |
|
| |
 |
Is the P-E (adjusted for goodwill) attractive to you? Relative to the average P-E of the S&P 500? |
 |
 |
|
| |
2. |
Coke's checklist has some problems, particularly for a stock which trades at 33x the eps estimate for next year: RORE has been declining during the last decade and is below 20%, while future estimates have been lowered time and time again. A new CEO was recently announced following Doug Ivester's two-year tenure which presided over the company's worst results in decades. Finally, the 20-year ROI of 13% is attractive, but hardly compelling (the 10-year ROI is 12%).
Operationally, North America continues to be intensely competitive, an intensity likely to only increase given Pepsi's renewed focus. At the same time, international operations which provide ¾ of income are being hit by three factors: weak economies and weak currencies generally and the aftermath of a health scare particular to Coke's products in Europe.
|
|
| |
3. |
In the face of all these concerns, is the stock a buy? The short answer is "yes" (the longer answer is "yes, but…"). Coke is facing many uncertainties, but it a company which justifies the benefit of the doubt, both in its operations and in its leadership.
The stock isn't a bargain, but to the extent you are invested in the market, it is in our opinion more attractive than the average, being one of the few investment-grade stocks and offering a higher estimated ROI than the average stock in the S&P 500 Index.
Suggestion: Go to W.E. Portfolio
|
|
 |
 |
 |
 |
 |
 |